As detailed in the letter attached herewith.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fundviser Capital's Board, at its meeting on 16th June 2025, approved increasing the Authorised Share Capital from Rs. 10 crore to Rs. 12.50 crore (1.25 crore equity shares of Rs. 10 each). The Board also approved issuing 64,85,000 Convertible Warrants on a preferential basis at Rs. 116 per warrant (face value Rs. 10 + premium of Rs. 106), aiming to raise approximately Rs. 7.52 crore. Allottees include promoter group entities (Trikaal Theatres, Mohit Prem Krishan Jain, Prem Krishan Jain, Kriti Mohit Jain, Renu Prem Jain) and 10 non-promoter strategic investors, with each warrant convertible into one equity share within 18 months. An Extra-Ordinary General Meeting has been scheduled for 15th July 2025 to seek shareholder approval for these actions.
The preferential warrant issue will dilute existing shareholders but brings in fresh capital from promoters and strategic investors, signaling confidence in the company. The promoter group is participating meaningfully, which is generally seen as a positive signal, though existing public shareholders will see their stake reduce once warrants are converted.